Larimar Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Larimar Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 19, 2026, with key proposals including director elections, executive compensation, auditor ratification, and a significant increase in authorized shares.
NASDAQ
Larimar Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on May 13, 2025, featuring proposals for director election, executive compensation approval, and auditor ratification.
NASDAQ
DEF 14A: Larimar Therapeutics Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Larimar Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on May 29, 2024, to vote on director elections, executive compensation, auditor ratification, and corporate governance matters.